Skip to main content
. Author manuscript; available in PMC: 2016 Mar 15.
Published in final edited form as: Gene Ther. 2016 Jan 21;23(3):272–282. doi: 10.1038/gt.2015.112

Figure 4. AAV2-2 with CBA promoter transduces both WT and diseased CSMN.

Figure 4

(a) Experimental approach showing direct injection of AAV2-2 CBA. Injections were performed at P30 and P60, and tissue was collected at P60 and P90, respectively. (b) Bar graphs represent mean percentage ± SEM of CSMN (eGFP+ cells, expressing Ctip2) and CPN (eGFP+ cells, expressing SATB2) transduction in both WT and hSOD1G93A mice at P60 and P90. (c) Representative images of P60 WT neurons transduced with AAV2-2 encoding eGFP under the CBA promoter. Arrows indicate eGFP+ neurons expressing Ctip2 and not SATB2. (d) Representative images of hSOD1G93A neurons transduced with AAV2-2 encoding eGFP under the CBA promoter. Arrows indicate eGFP+ neurons expressing Ctip2 and not SATB2. No statistical differences were detected by one-way ANOVA and Tukey’s multiple comparisons test. Scale bar = 20 μm.